Owkin Enters Collaboration Agreement With Merck & Co., Inc., Rahway, N.J., USA

Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development and diagnostics, announced that it has entered into a collaboration agreement with Merck & Co., Inc., Rahway, N.J., USA to develop and commercialize AI-powered digital pathology diagnostics for the EU market.